Sponsors / DFTX
DFTX

Definium Therapeutics US, Inc.

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
7Trials in this database
17Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept TrialNCT05200936Definium Therapeutics US, Inc.Phase 2Completed2023-11-06Actual
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064Definium Therapeutics US, Inc.Phase 2Completed2023-10-06Actual
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228Definium Therapeutics US, Inc.Phase 3Active not recruiting2026-07-15Actual
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)NCT06809595Definium Therapeutics US, Inc.Phase 3Active not recruiting2026-08-13Actual
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844Definium Therapeutics US, Inc.Phase 3Active not recruiting2026-05-20Actual
A Phase 2A Trial of DT402 for Autism Spectrum DisorderNCT07303907Definium Therapeutics US, Inc.Phase 2Recruiting2027-08Estimated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689Definium Therapeutics US, Inc.Phase 3Recruiting2027-09Estimated

Latest recorded trial changes

A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)

NCT06941844 · Definium Therapeutics US, Inc.

· 3 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

140 participants (planned)

+ After

149 participants (actual)

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source